OncoHost’s PROphet® Platform to Support Henlius US-Based Phase III Trial for Patients with Extensive-Stage Small Cell Lung Cancer
- Tuesday, October 3, 2023, 7:16
- PR Newswire
- Add a comment
Proteomic Pattern Recognition Technology to Help Identify and Characterize Potential Resistance Patterns in Recruited Patients, Provide Correlative Biomarkers to Guide Outcomes BINYAMINA, Israel , Oct. 3, 2023 /PRNewswire/ — OncoHost, a technology company transforming the approach to…
About the Author
admin has written 20655 stories on this site.